Home › Funds › Farallon Capital Management › VRTX
Farallon Capital Management position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q4 2023)55.00K sh
Reported value held$22.38M
Portfolio Weight0.11%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 202.00K | $70.24M | New |
| Q4 2023 | 55.00K | $22.38M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026